AI Terminal
Dr. Martens PLC
Board/Management Information • Apr 13, 2021
5055_rns_2021-04-13_10b4004e-1669-483f-a2b2-f6a752e5b27c.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 2083V
Dr. Martens PLC
13 April 2021
13 April 2021
Dr. Martens plc
Appointment of Joint Corporate Brokers
Dr. Martens plc today announces the appointment of Goldman Sachs International, Investec Bank plc and Morgan Stanley & Co. International plc as its joint corporate brokers, with immediate effect.
Enquiries:
Investors and analysts
Bethany Barnes, Director of Investor Relations
+44 7825 187465
Media
Finsbury Glover Hering
Rollo Head, James Leviton
+44 20 7251 3801
Gill Hammond, Director of Communications
+44 7384 214 248
About Dr. Martens plc:
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange in January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPQLLFFFZLXBBK